Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2 - - GEO DataSets

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2

Analysis of endocrine-resistant LY2 breast cancer cells depleted of p160 steroid coactivator protein SRC-1 and treated with tamoxifen. SRC-1 is central to the development of the endocrine resistant phenotype. Results provide insight into the molecular basis of endocrine resistant breast cancer.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 agent, 2 genotype/variation sets

Platform:: GPL570
Series:: GSE28645
14 Samples

Download data: CEL

DataSet

Accession:: GDS4095

ID:: 4095

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

GEO DataSets

Functional Genomics Studies

Result Filters

Send to:

Links from GEO Profiles

Supplemental Content

Related information

Important Links

Recent activity